BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Type:  Journal Contribution

Results 101-120 of 180 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1012008Exploring and validating surrogate endpoints in colorectal cancerBURZYKOWSKI, Tomasz; BUYSE, Marc; Yothers, Greg; Sakamoto, Junichi; Sargent, DanJournal ContributionA1
1022008Endpoints and surrogate endpoints in colorectal cancer: a review of recent developmentsPIEDBOIS, P.; BUYSE, MarcJournal ContributionA1
1032008Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerPiccart-Gebhart, Martine J.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sledge, George; Carmichael, James; Luck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
1042008Individual- and trial-level surrogacy in colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Michiels, Stefan; Carroll, KevinJournal ContributionA1
1052008Reformulating the hazard ratio to enhance communication with clinical investigatorsBUYSE, MarcJournal ContributionA1
1062007Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!Collette, Laurence; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
1072007Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerde Gramont, Aimery; BUYSE, Marc; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Cervantes, Andres; Figer, Arie; Lledo, Gerard; Flesch, Michel; Mineur, Laurent; Carola, Elisabeth; Etienne, Pierre-Luc; Rivera, Fernando; Chirivella, Isabel; Perez-Staub, Nathalie; Louvet, Christophe; André, Thierry; Tabah-Fisch, Isabelle; Tournigand, ChristopheJournal ContributionA1
1082007Progression-free survival is a surrogate for survival in advanced colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, Kevin; Michiels, Stefan; Sargent, Daniel J.; Miller, Langdon L.; Elfring, Gary L.; Pignon, Jean-Pierre; Piedbois, PascalJournal ContributionA1
1092006Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trialBogaerts, J.; Cardoso, F.; BUYSE, Marc; Braga, S.; Loi, S.; Harrison, J. A.; Bines, J.; Mook, S.; Decker, N.; Ravdin, P.; Therasse, P.; Rutgers, E.; van't Veer, L. J.; Piccart, M.Journal ContributionA1
1102006Alternative clinical end points in rectal cancer—are we getting closer?Glynne-Jones, R; Mawdsley, S; Pearce, T; BUYSE, MarcJournal ContributionA1
1112006Analysis of oxaliplatin reintroduction in patients with advanced colorectal cancer (CRC) treated with FOLFOX4 or FOLFOX7 in the optimox studyBUYSE, Marc; Quinaux, E; CORTINAS ABRAHANTES, Jose; Tournigand, C; Cervantes, A; Figer, A; André, Thierry; Tabah-Fisch, I; De Gramont, AJournal ContributionM
1122006Current issues in adjuvant treatment of stage II colon cancerAndré, Thierry; Sargent, D; Tabernero, J; O'Connell, M; BUYSE, Marc; Sobrero, A; Misset, J.L.; Boni, C; de Gramont, AJournal ContributionA1
1132006Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validationBURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
1142006A unifying approach for surrogate marker validation based on Prentice's criteriaALONSO ABAD, Ariel; MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc; VANGENEUGDEN, TonyJournal ContributionA1
1152005A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancerBURZYKOWSKI, Tomasz; Piccart, MJ; Sledge, G; Carmichael, J; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Therasse, P; BUYSE, MarcJournal ContributionM
1162005Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trialsPiccart, MJ; BURZYKOWSKI, Tomasz; Sledge, G; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Carmichael, J; BUYSE, Marc; Therasse, PJournal ContributionM
1172005Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 tandomized trialsSargent, Daniel J.; Wieand, Harry S.; Haller, Daniel G.; Gray, Richard; Benedetti, Jacqueline; BUYSE, Marc; Labianca, Roberto; Seitz, Jean Francois; O'Callaghan, Christopher J.; Francini, Guido; Grothey, Axel; O'Connell, Michael; Catalano, Paul J.; Blanke, Charles D.; Kerr, David; Green, Erin; Wolmark, Norman; André, Thierry; Goldberg, Richard M.; De Gramont, AimeryJournal ContributionA1
1182005Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials.BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, K; Michiels, Stefan; Pignon, JP; Piedbois, PJournal ContributionM
1192004Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpointsALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, MarcJournal ContributionA1
1202004A perspective on surrogate endpoints in controlled clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, MarcJournal ContributionA1
show all